Abstracts from 2014 through the most recent CROI can be viewed in this searchable database once they have been presented at the conference. Abstract Contents: The searchable database includes abstract text as submitted by the authors prior to CROI. Study data might be updated during the presentation at CROI. Please refer to the electronic poster or webcast for updates. Searching the Abstract Database: Enter the criteria below and click the “Search” button. After the search has been entered, the results will appear below the search form.

CROI conference materials (eg, the conference program, Abstract eBook, electronic posters, CROI logo, etc) are protected by copyright. Permission to replicate or reproduce these elements, in whole or in part, must be obtained from the CROI Conference Manager, the International Antiviral Society-USA (IAS-USA). Study data (including figures within abstracts or electronic posters) are the property of the study authors. Permission to use data and figures cannot be given by IAS–USA unless it is for regulatory reasons. For more information, please email CROIabstracts@iasusa.org.

Search Results

1277 Results

390 – Understanding NLRP3 Inflammasome Activation at the Intersection of HIV and Aging

Background With long-term survival of people living with HIV (PLH) increased rates of age-related diseases have been observed. Persistent immune activation in PLH and age-related chronic inflammation are hypothesized to be drivers for the development of such diseases. The NLRP3 inflammasome is a multiprotein complex that forms in response to stimulation of pattern recognition receptors…

374 – The Molecular Cargo of Exosomes Is Able to Discriminate Between PLWH With or Without NADCs

Background Non-Aids Defining Cancers (NADCs) are the main cause of morbidity and death from non-AIDS events (ENOS) in PLWH, whose death rate is higher than in the general population without HIV infection but who suffer from these same NADCs. However, the mechanisms that explain this are unknown. It has been suggested that exosomes derived from…

349 – Transcriptionally Active Defective HIV-1 Proviruses Persist in All CD4 T-Cell Subsets During ART

Background More than 95% of HIV-1 proviruses detected are defective but often associated with RNA transcripts during antiretroviral therapy (ART). These transcriptionally active defective proviruses may contribute to persistent immune activation seen in people with HIV (PWH) receiving ART. The distribution and persistence of these transcriptionally active defective proviruses has not been described. Methods 11…

351 – Similar Intact and Defective HIV Provirus Frequency in Suboptimal Immune Responders and Controls

Background A significant percentage of PWH who start or restart antiretroviral therapy (ART) with low CD4+ counts fail to mount a robust CD4+ T cell response despite suppressive ART (suboptimal immune responders, SoIRs). A correlation between the frequency of infected CD4+ T cells and low CD4+ counts on ART has been reported. However, these studies…

373 – Changes in Serum Level of Cell-Free Mitochondrial DNA Fragments in Acute and Chronic HIV Infection

Background Circulating cell-free mitochondrial DNA (ccf-mtDNA) fragments are released into the bloodstream following cell death, can activate the innate immune system, and have been associated with aging-related outcomes, including frailty, in the general population. Data on ccf-mtDNA levels during both acute and chronic phases of HIV infection remain limited.  We hypothesized that HIV infection is…

392 – Lobule Zone-Dependent Accumulation of Vd1 and Vd2 gd-T Cells in the Livers of SIV+ Infant Macaques

Background Gamma-delta (gd) T cells are enriched in liver and barrier tissues compared to the peripheral blood and aid in the response to gut-derived antigens and tissue homeostasis. They are depleted from the blood during HIV infection, yet what happens to them and the importance of the effect are not well characterized. We hypothesized that…

380 – Extracellular Vesicles From the Cells Harboring HIV Defective Provirus Initiate Inflammatory Cascade

Background It has been demonstrated that over 95% of provirus present in the peripheral blood of people living with HIV on combination antiretroviral therapy are defective. Defective viruses have long been considered biologically irrelevant, as they cannot encode infectious viruses. However, recent studies have shown that these defective viruses are translationally active, raising potential concerns…

335 – The Influence of Chronic HIV Inflammation on Post-COVID Immune Activation

Background People with HIV (PWH) appear to be 2-4x more likely to develop long COVID after SARS-CoV-2 infection than people without HIV (PWOH). This is potentially linked to the heightened immune activation and inflammatory state typical of chronic HIV despite effective antiretroviral therapy. Here, we evaluated whether the shifts in monocyte and T cell populations…

849 – ALDH Activity as a New Marker of Subclinical Atherosclerosis During ART-Treated HIV-1 Infection

Background Antiretroviral therapy (ART) controls viral replication in people with HIV (PWH), but viral reservoirs (VR) persist and represent a cause for the occurrence of age-related comorbidities, e.g. cardiovascular disease (CVD). We demonstrated that retinoic acid (RA, a vitamin A derivative) increases HIV-1 outgrowth from VR and that microbiota components (e.g., Staphylococcus aureus) promote ALDH…

494 – Loss of Virologic Control 32 Years After HIV-1 Diagnosis in an Exceptional Elite Controller

Background HIV-1 Exceptional Elite Controllers (EEC) maintain undetectable viremia and halt disease progression more than 20 years after infection in the absence of treatment and may be considered as functionally cured.  However, loss of control in these individuals is unknown. In this study we performed a detailed, longitudinal characterisation of the HIV-1 reservoir, viral evolution…